Loading clinical trials...

Terumo Aortic Global Endovascular Registry | Clinical Trials | Clareo Health

RECRUITING

Terumo Aortic Global Endovascular Registry

A Global Post Market Evaluation of Terumo Aortic Endovascular Grafts

NCT04246463•Vascutek Ltd.

Summary

Multi-arm, multi-center, open label, prospective observational registry designed to obtain safety and performance data on the use of CE marked and custom Terumo Aortic endovascular grafts.

Detailed Description

Post Market registry collecting real world, post-approval safety, performance, patient reported outcomes and health economic data on patients treated with Terumo Aortic endovascular stent-grafts in standard clinical practice.

Eligibility

Age

18 - No limit years

Sex

ALL

Healthy Volunteers

Inclusion Criteria

•Minimum age as per local regulations
•Indication for aortic endovascular repair with an approved or CE marked by a Regulatory body or custom-made Terumo Aortic Endovascular graft
•Ability to provide informed consent
•o Emergent cases (typically younger patients with traumatic injuries) are not excluded if there is IRB/EC agreement to allow consent after intervention (i.e. consent to study participation, not to treatment) or use of a Legally Authorized Representative (LAR).
•Willingness to comply with the registry protocol
•Willingness to adhere to follow-up visits Note: Patients currently enrolled and actively participating within the TREO registry (IP-0020-16) can have their data migrated from TREO to the TiGER registry where local EC approval has been obtained and the patient has been reconsented to TiGER for longer follow-up.

Exclusion Criteria

•Patient is unable or unwilling to comply with the study follow-up regime. Patient is contraindicated per the IFU, or has any other medical, social or psychological problems that in the opinion of the investigator preclude them from receiving treatment as well as the procedures and evaluations pre and post procedure.

Locations (58)

Long Beach Memorial Medical Center

Long Beach, California, United States

University of Colorado Anschutz Medical Campus

Aurora, Colorado, United States

UC Health Memorial Hospital Center

Colorado Springs, Colorado, United States

Yale University

New Haven, Connecticut, United States

MedStar Washington Hospital Center

Washington D.C., District of Columbia, United States

University of Florida

Gainesville, Florida, United States

Loyola University of Chicago (Loyola)

Chicago, Illinois, United States

Ascension St. Vincent Heart Center

Indianapolis, Indiana, United States

University of Michigan

Ann Arbor, Michigan, United States

Cooper University Hospital

Camden, New Jersey, United States

Key Dates

Start Date

December 17, 2019

Primary Completion Date

November 1, 2029

Completion Date

November 1, 2030

Last Updated

March 13, 2026

Enrollment

1,000

ESTIMATED participants

Conditions

Abdominal Aortic AneurysmThoracic Aortic AneurysmSurgery

Interventions

Thoracic

DEVICE

Abdominal

DEVICE

Custom Device

DEVICE

Illiac Artery

DEVICE

Contacts

Michelle Durnan

CONTACT

+44 141 343 0195 m.durnan@terumoaortic.com

Sammy Jassal

CONTACT

+44 141 343 0195 s.dhaliwal@terumoaortic.com

Evaluation of Resection Techniques for Pancreatic Tumors

NCT05128890

SurgeryLiver Tumor+1 more

View study

RECRUITINGNA

EOIFP Block Versus OSTAP Block for Upper Abdominal Surgery

NCT06409156

Open Abdominal Surgery

View study

RECRUITINGEARLY_PHASE1

PET Imaging of MMP Activation in AAA: Clinical Component

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: March 13, 2026Data synced to Clareo: March 29, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions

Terumo Aortic Global Endovascular Registry

Inclusion Criteria

Exclusion Criteria

Evaluation of Resection Techniques for Pancreatic Tumors

EOIFP Block Versus OSTAP Block for Upper Abdominal Surgery

PET Imaging of MMP Activation in AAA: Clinical Component

Ultrasound vs. Auscultation and Fiberoptic Bronchoscopy for Double-Lumen Tube Placement

Comparison of Ultrasound-Guided Injection With Median Nerve Decompression Surgery in Carpal Tunnel Syndrome

Factor VIII Inhibitor Bypass Activity (FEIBA) Versus Fresh Frozen Plasma As First Line Therapy For Bleeding After Cardiac Surgery